Is WVE Worth Buying in 2026?

Wave Life Sciences Ltd. Ordinary Shares

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-07-26

Here’s whether Wave Life Sciences Ltd. Ordinary Shares (WVE) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-4.21% over 10 days); weak 1-year return of -30.8%; 3-month momentum negative (-19.1%). Currently 73.3% off its 52-week high. Score: -6/7.

Ready to act on this? 📈 Trade on Webull

WVE is trading below its 200-day MA ($9.65) — a key warning sign the longer-term trend is under pressure. An RSI of 34.9 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -30.8% compares to +16.5% for SPY (trailed the market by 47.2%). The current 73.3% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $6,925 today
vs. S&P 500 (SPY) — same period trailed market by 47.2%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($9.65)
Above 50-day MA ($6.07)
RSI(14) neutral zone (30–70) — currently 34.9
Positive return (-30.8%)
!Within 10% of period high (−73.3%)
Period Range $5.81
$5.02 $21.73
RSI (14) 34.9
0 · OversoldOverbought · 100

Key Metrics

Price$5.81
Period Return-30.8%
Period High$21.73
Period Low$5.02
Drawdown−73.3%
MA-50$6.07
MA-200$9.65
RSI (14)34.9
Avg Volume (30d)2.9M
vs. SPYtrailed by 47.2%
Return Rank#760 of 999

Trade WVE

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers